46 search results for: pediatric

KOL Video Interview – Dr. Eric Simpson
expert video

KOL Video Interview – Dr. Eric Simpson

Dermatology
In this exclusive KOL interview, Dr. Eric Simpson explores the cumulative, long-term impact of atopic dermatitis and highlights the potential benefits of initiating treatment early to help manage disease burden.
View more
UEGW 2024 | Latest Clinical Evidence for Biologics in EoE
expert video

UEGW 2024 | Latest Clinical Evidence for Biologics in EoE

Gastroenterology
Prof. Salvatore Oliva discusses the latest clinical data for EoE that included patients from childhood to adulthood.
View more
ESPGHAN 2024 | Clinical Management of Young Children With EoE
expert video

ESPGHAN 2024 | Clinical Management of Young Children With EoE

Gastroenterology
Dr. Dhandapani Ashok highlights treatment options for patients with EoE aged 12 years and younger and the importance of shared decision-making.
View more
Children and EoE: More Than Just Being a Picky Eater
expert video

Children and EoE: More Than Just Being a Picky Eater

Gastroenterology
Join Prof. Alexandra Papadopoulou as she reviews the multifaceted burden of children with EoE.
View more
ESPGHAN 2024 | Clinical Management of EoE in Adolescents to Adulthood
expert video

ESPGHAN 2024 | Clinical Management of EoE in Adolescents to Adulthood

Gastroenterology
Prof. Salvatore Oliva discusses the latest treatment options for adolescents and adults with EoE and the importance of effective transition of care.
View more
UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management
expert video

UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management

Gastroenterology
Prof. Salvatore Oliva and Dr. Milli Gupta discuss the importance of long-term care, multidimensional assessment, and the latest data for biologics.
View more
Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, and CSU)​ - Panel Discussion
expert video

Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, and CSU)​ - Panel Discussion

Dermatology
Panel discussion exploring how itch differs across AD, PN, and CSU, and how it affects pediatric patients with AD.
View more
ADVENT On Air - Dermatology
Podcast

ADVENT On Air | Expert Discussions in Dermatology

Dermatology
Listen to the latest updates in type 2 inflammatory science and associated skin diseases, brought to you by leading dermatology experts in the field. ADVENT On Air podcasts feature scientific conversations that explore new research into the pathophysiology, clinical features, and disease burden for a range of dermatological diseases linked to type 2 inflammation, including atopic dermatitis (AD) and prurigo nodularis (PN). Hear new insights revealed through expert-led conversations below or in your preferred podcast app.

View more
Prevalence of Food Allergy and Other Atopic Comorbidities in Children With AD
expert video

Prevalence of Food Allergy and Other Atopic Comorbidities in Children With AD

Dermatology
In this highlight video from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Mark Boguniewicz discusses the prevalence of food sensitization and food allergy in pediatric patients with AD, clarifying the difference between the two. Dr Boguniewicz also discusses the prevalence of other atopic comorbidities in children with AD
View more
Identification and Management of AD Uncontrolled With Topical Therapies in Children
expert video

Identification and Management of AD Uncontrolled With Topical Therapies in Children

Dermatology
In this expert interview video focusing on topics from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Perla Lansang discusses how to identify pediatric patients with AD uncontrolled with topical therapies, considerations for the next step in care for these patients, and the potential benefits of early intervention with systemic treatment
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: CanadaChange country/region